Detalhe da pesquisa
1.
Novel Immunoliposome Technology for Enhancing the Activity of the Agonistic Antibody against the Tumor Necrosis Factor Receptor Superfamily.
Mol Pharm
; 15(9): 3729-3740, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29648839
2.
Fusogenic liposome can be used as an effective vaccine carrier for peptide vaccination to induce cytotoxic T lymphocyte (CTL) response.
Biol Pharm Bull
; 28(1): 192-3, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15635192
3.
Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
Biochem Biophys Res Commun
; 325(2): 500-5, 2004 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-15530420